---
figid: PMC9508642__gr8
pmcid: PMC9508642
image_filename: gr8.jpg
figure_link: /pmc/articles/PMC9508642/figure/f0040/
number: Fig. 8
figure_title: ''
caption: Schematic diagram of molecular targets of sorafenib and perindopril.sorafenib
  and perindopril inhibit Wnt/ β-catenin pathway whereas perindopril potentiates this
  inhibition through dampening leptin level. Leptin is associated with Akt phosphorylation
  and inactivation of GSK 3β (more details in text).
article_title: 'Perindopril sensitizes hepatocellular carcinoma to chemotherapy: A
  possible role of leptin / Wnt/ β-catenin axis with subsequent inhibition of liver
  cancer stem cells.'
citation: Sherin Zakaria, et al. Saudi Pharm J. 2022 Aug;30(8):1170-1180.
year: '2022'

doi: 10.1016/j.jsps.2022.06.019
journal_title: 'Saudi Pharmaceutical Journal : SPJ'
journal_nlm_ta: Saudi Pharm J
publisher_name: Elsevier

keywords:
- Perindopril
- Leptin
- Wnt
- β-catenin
- ALDH1
- ABC, ATP binding box
- ACEI, Angiotensin converting enzyme inhibitors
- ALT, Alanineaminotransferase
- APC, adenomatous polyposis coli protein
- AST, Aspartate aminotransferase
- ALDH1, Aldehyde dehydrogenases 1
- ANG II, Angiotensin II
- DENA, Diethylnitrosamine
- EpCAM, Epithelial cell adhesion molecule
- GSK 3β, glycogen synthase kinase-3β
- HCC, Hepatocellular carcinoma
- LCSC, Liver cancer stem cells
- MMP-9, Metalloproteinase-9
- mTOR, Mammalian target of rapamycin
- PBS, Phosphate-buffered saline
- PDGFR-β, platelet-derived growth factor receptor
- PRIN, Perindopril
- SOR, Sorafenib
- VEGF, Vascular endothelial growth factor

---
